Literature DB >> 11792807

Pigment epithelium-derived factor (PEDF) in neuroblastoma: a multifunctional mediator of Schwann cell antitumor activity.

S E Crawford1, V Stellmach, M Ranalli, X Huang, L Huang, O Volpert, G H De Vries, L P Abramson, N Bouck.   

Abstract

Neuroblastoma is notable for its cellular heterogeneity and unpredictable outcome. Tumors are a variable mixture of primitive malignant neuroblasts, more differentiated ganglionic cells, Schwann and endothelial cells. Although often fatal, neuroblastomas can spontaneously regress, possibly due to favorable autocrine and paracrine interactions among these cells. Here, pigment epithelium-derived factor (PEDF), a potent inhibitor of angiogenesis and inducer of neural differentiation, is shown to be produced by ganglionic cells and Schwann cells, but not by more primitive tumor cells. Although undifferentiated neuroblastoma tumor cell secretions were angiogenic primarily due to vascular endothelial growth factor, secretions of Schwann cells were anti-angiogenic due to PEDF. In addition, PEDF was the major factor responsible for Schwann cell's ability to induce tumor cell differentiation in vitro and recombinant PEDF had the same effect in vitro and in vivo. Both the growth and the survival of Schwann cells were enhanced by PEDF. Thus PEDF may serve as a multifunctional antitumor agent in neuroblastomas, inhibiting angiogenesis while promoting the numbers of Schwann cells and differentiated tumor cells that in turn produce PEDF, suggesting that its clinical administration could stimulate a multifaceted antitumor feedback loop with the potential to limit and possibly regress tumor growth.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11792807     DOI: 10.1242/jcs.114.24.4421

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  56 in total

1.  Similarity and difference in the effects of peptides TGENHR and TQVEHR on HL-60 promyelocytes and Purkinje cells of rat cerebellar vermis.

Authors:  S S Zhokhov; I A Kostanyan; N V Gibanova; E A Surina; Z I Storozheva; I I Babichenko; V M Lipkin
Journal:  Dokl Biol Sci       Date:  2004 Jan-Feb

2.  Inhibition of tumor cell surface ATP synthesis by pigment epithelium-derived factor: implications for antitumor activity.

Authors:  Monika Deshpande; Luigi Notari; Preeti Subramanian; Vicente Notario; S Patricia Becerra
Journal:  Int J Oncol       Date:  2012-04-10       Impact factor: 5.650

3.  Age- and cell cycle-dependent changes in EPC-1/PEDF promoter activity in human diploid fibroblast-like (HDF) cells.

Authors:  Toshihiko Kojima; Ken-ichi Nakahama; Kiyotaka Yamamoto; Hiroshi Uematsu; Ikuo Morita
Journal:  Mol Cell Biochem       Date:  2006-07-31       Impact factor: 3.396

4.  A career perspective on the discipline of neurochemistry.

Authors:  George H DeVries
Journal:  Neurochem Res       Date:  2009-01       Impact factor: 3.996

5.  PEDF regulates plasticity of a novel lipid-MTOC axis in prostate cancer-associated fibroblasts.

Authors:  Francesca Nardi; Philip Fitchev; Omar E Franco; Jelena Ivanisevic; Adrian Scheibler; Simon W Hayward; Charles B Brendler; Michael A Welte; Susan E Crawford
Journal:  J Cell Sci       Date:  2018-07-11       Impact factor: 5.285

6.  Pigment epithelium-derived factor binds to hyaluronan. Mapping of a hyaluronan binding site.

Authors:  S Patricia Becerra; L Alberto Perez-Mediavilla; John E Weldon; Silvia Locatelli-Hoops; Preenie Senanayake; Luigi Notari; Vicente Notario; Joe G Hollyfield
Journal:  J Biol Chem       Date:  2008-09-19       Impact factor: 5.157

7.  Cross-talk between Schwann cells and neuroblasts influences the biology of neuroblastoma xenografts.

Authors:  Shuqing Liu; Yufeng Tian; Alexandre Chlenski; Qiwei Yang; Peter Zage; Helen R Salwen; Susan E Crawford; Susan L Cohn
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

8.  Pigment-epithelium-derived factor (PEDF) occurs at a physiologically relevant concentration in human blood: purification and characterization.

Authors:  Steen V Petersen; Zuzana Valnickova; Jan J Enghild
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

9.  Stromal heparan sulfate differentiates neuroblasts to suppress neuroblastoma growth.

Authors:  Erik H Knelson; Angela L Gaviglio; Jasmine C Nee; Mark D Starr; Andrew B Nixon; Stephen G Marcus; Gerard C Blobe
Journal:  J Clin Invest       Date:  2014-06-17       Impact factor: 14.808

10.  Vascular endothelial growth factor in children with neuroblastoma: a retrospective analysis.

Authors:  Gordana Jakovljević; Srana Culić; Jasminka Stepan; Aleksandra Bonevski; Sven Seiwerth
Journal:  J Exp Clin Cancer Res       Date:  2009-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.